Scientists Discover Genetic Variants Responsible for Mucinous Ovarian Cancer
Scientists have identified 3 gene variants of HOXD9, which can help explain the development of ovarian cancer.
Scientists at the Keck School of Medicine, University of Southern California, have identified 3 gene variants of HOXD9, which can help explain the development of the fourth most common cause of cancer in the United States, ovarian cancer.
"By finding these genetic markers, we begin to understand more about the biology of the disease itself," said Dr Simon Gayther, the corresponding author on the manuscript that was published in Nature Genetics, in a statement.
The retrospective study was conducted in 1644 women diagnosed with mucinous ovarian cancer and 21000 women without the disease, under the umbrella of the Collaborative Oncological Gene-environment Study, created to determine the risks of breast, ovarian, and prostate cancer.
Read more on ScienceDaily:
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Related Articles
- Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis
September 18th 2025
- Iron Dysregulation Linked to MS Progression, Review Finds
September 18th 2025
- Metabolic Issues More Common in Patients With HIV
September 18th 2025
- Barriers to Gender-Affirming Surgery Persist Despite High Satisfaction Rate
September 18th 2025